REICH SIEGFRIED (EVP & Chief Scientific Officer) received a stock award from TURNING POINT THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/10/2021ACC: 0001209191-21-009364
Officer· EVP & Chief Scientific Officer
Since Mar 2020
+21.15K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
21.15K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+3.85K
Price / share
—
Trade value
—
% of position
New position
2/8/2021
0.00→3.85K
Total
Net shares
+3.85K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/8/2021 | A · Award | +3.85K | — | — | New position | 0.00 | 3.85K |
| Total | +3.85K | $0.00 | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
17.30K shares
Shares
+17.30K
Strike price
140.01
Held after
17.30K
Exercisable
—
2/8/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock17.30K shares | 2/8/2021 | A · Award | +17.30K | 140.01 | — | 17.30K |